Ropeginterferon alfa-2b for treating polycythaemia vera without symptomatic splenomegaly [ID1596]

  • In development
  • GID-TA10497
  • Expected publication date: TBC

Register as a stakeholder

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators